However, regardless of CAR expression, combining H101 with systemic PD-1 blockade resulted in the inhibition of synergistic tumor growth and prolonged the survival of tumor-bearing mice, compared with treatment with each agent alone. The gene discussed is PDCD1; the disease is neoplasm.